sabrilex 500 mg granulat til oral opløsning
sanofi a/s - vigabatrin - granulat til oral opløsning - 500 mg
sabril 500 mg granulat til oral opløsning
orifarm a/s - vigabatrin - granulat til oral opløsning - 500 mg
eradicoat max vandopløseligt koncentrat
certis belchim b.v. - maltodextrin - vandopløseligt koncentrat - 476 g/l maltodextrin
primylis 10 mg tabletter
mylan ab - lisinoprildihydrat - tabletter - 10 mg
primylis 20 mg tabletter
mylan ab - lisinoprildihydrat - tabletter - 20 mg
drospera 3+0,02 mg filmovertrukne tabletter
exeltis healthcare s.l - drospirenon, ethinylestradiol - filmovertrukne tabletter - 3+0,02 mg
xarelto
bayer ag - rivaroxaban - arthroplasty, replacement; venous thromboembolism - antitrombotiske midler - xarelto, co-gives sammen med acetylsalicylsyre (asa) alene eller sammen med asa plus clopidogrel eller ticlopidin, der er indiceret til forebyggelse af atherothrombotic hændelser hos voksne patienter efter en akut koronar syndrom (acs) med forhøjet kardiale biomarkører. xarelto, co-administered with acetylsalicylic acid (asa), is indicated for the prevention of atherothrombotic events in adult patients with coronary artery disease (cad) or symptomatic peripheral artery disease (pad) at high risk of ischaemic events. forebyggelse af venøs tromboembolisme (vte) hos voksne patienter, der gennemgår valgfri hofte- eller knæskifteoperation. behandling af dyb venøs trombose (dvt) og lungeemboli (pe), og forebyggelse af recidiverende dvt og pe i voksne. adultsprevention of stroke and systemic embolism in adult patients with non-valvular atrial fibrillation with one or more risk factors, such as congestive heart failure, hypertension, age ≥ 75 years, diabetes mellitus, prior stroke or transient ischaemic attack. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing from 30 kg to 50 kg after at least 5 days of initial parenteral anticoagulation treatment. paediatric population treatment of venous thromboembolism (vte) and prevention of vte recurrence in children and adolescents aged less than 18 years and weighing more than 50 kg after at least 5 days of initial parenteral anticoagulation treatment.
enalaprilmaleat/lercanidipinhydrochlorid "accord" 10+10 mg filmovertrukne tabletter
accord healthcare b.v. - enalaprilmaleat, lercanidipinhydrochlorid - filmovertrukne tabletter - 10+10 mg
leverette 21 150+30 mikrogram filmovertrukne tabletter
exeltis healthcare s.l - ethinylestradiol, levonorgestrel - filmovertrukne tabletter - 150+30 mikrogram
enalaprilmaleat/lercanidipinhydrochlorid "accord" 20+10 mg filmovertrukne tabletter
accord healthcare b.v. - enalaprilmaleat, lercanidipinhydrochlorid - filmovertrukne tabletter - 20+10 mg